Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs

BACKGROUND: Decisions relating to the funding of new drugs are becoming increasingly challenging due to a combination of aging populations, rapidly increasing list prices, and greater numbers of drug-indication pairs being brought to market. This is especially true in cancer, where rapid list price...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Public Health
Main Authors: Costa, Sarah, Bentley, Colene, Regier, Dean A., McTaggart-Cowan, Helen, Mitton, Craig, Burgess, Michael M., Peacock, Stuart J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6647147/
https://ncbi.nlm.nih.gov/pubmed/31331312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-019-7303-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados